[The study and treatment of dystonias in childhood]

Area of Science:

• Neurology
• Pediatrics
• Genetics

Context:

• Dystonia is the third most common childhood movement disorder, following spasticity and tics.
• Childhood dystonia often presents as generalized forms and is frequently secondary to conditions like cerebral palsy.
• Heredo-degenerative causes are crucial to consider due to specific genetic counseling, prognostic, and therapeutic implications.

Purpose:

• To review the etiology, diagnostic approaches, and treatment strategies for childhood dystonia.
• To delineate the clinical features of common primary childhood dystonias, including DYT1 and dopa-responsive dystonias (DRD).
• To discuss management options based on dystonia distribution, from focal to generalized forms.

Summary:

• Generalized dystonia is more prevalent in children than adults, with cerebral palsy being a common cause of secondary dystonia.
• Primary dystonias like DYT1 and DRD (caused by GCH1 mutations or other neurotransmitter pathway defects) require specific diagnostic consideration.
• Treatment varies by distribution: botulinum toxin type A for focal dystonia, oral medications for generalized forms, and intrathecal baclofen or deep brain stimulation for severe cases.

Impact:

• Understanding the diverse etiologies of childhood dystonia is essential for accurate diagnosis and management.
• Tailored pharmacological and surgical interventions can lead to significant symptom improvement and enhanced quality of life for affected children.
• This review provides a comprehensive overview for clinicians managing pediatric movement disorders, emphasizing the complexity and treatability of dystonia.